Charlotte Hellgren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Charlotte Hellgren has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Inger Sundström-Poromaa
Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
9 shared publications - Alkistis Skalkidou
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
6 shared publications - Erika Comasco
Uppsala University
4 shared publications Helena Åkerud
4 shared publicationsAlkistis Skalkidou
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
3 shared publications- Elisabet Stener-Victorin
Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden
2 shared publications
Latest Publications
- Open Access
- 5 December 2019
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 19 (1) , 1-13
The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study
Background: Antenatal depression affects 10–20% of pregnant women. Around 2–4% of European pregnant women use antidepressant treatment, most commonly selective serotonin reuptake inhibitors (SSRIs). Poor pregnancy outcomes, such as preterm birth and low birth weight, have been described in women with antenatal depression and in pregnant women on SSRI treatment. However, the effects of antenatal depression and antidepressant treatment on the placenta are largely unknown. The aim of this work was to compare placental gene and protein expression in healthy women, women with untreated antenatal depression and women on antidepressant treatment during pregnancy. Methods: Placental samples from 47 controls, 25 depressed and 45 SSRI-treated women were analysed by means of qPCR using custom-designed TaqMan low-density arrays (TLDAs) for 44 genes previously known to be involved in the pathophysiology of depression, and expressed in the placenta. Moreover, placental protein expression was determined by means of immunohistochemistry in 37 healthy controls, 13 women with untreated depression and 21 women on antidepressant treatment. Statistical comparisons between groups were performed by one-way ANOVA or the Kruskal–Wallis test. Results: Nominally significant findings were noted for HTR1A and NPY2R, where women with untreated depression displayed higher gene expression than healthy controls (p < 0.05), whereas women on antidepressant treatment had similar expression as healthy controls. The protein expression analyses revealed higher expression of HTR1A in placentas from women on antidepressant treatment, than in placentas from healthy controls (p < 0.05). Conclusion: The differentially expressed HTR1A, both at the gene and the protein level that was revealed in this study, suggests the involvement of HTR1A in the effect of antenatal depression on biological mechanisms in the placenta. More research is needed to elucidate the role of depression and antidepressant treatment on the placenta, and, further, the effect on the fetus.
- 5 December 2019
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 19 (1) , 1-13
Open AccessThe effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study
Background: Antenatal depression affects 10–20% of pregnant women. Around 2–4% of European pregnant women use antidepressant treatment, most commonly selective serotonin reuptake inhibitors (SSRIs). Poor pregnancy outcomes, such as preterm birth and low birth weight, have been described in women with antenatal depression and in pregnant women on SSRI treatment. However, the effects of antenatal depression and antidepressant treatment on the placenta are largely unknown. The aim of this work was to compare placental gene and protein expression in healthy women, women with untreated antenatal depression and women on antidepressant treatment during pregnancy. Methods: Placental samples from 47 controls, 25 depressed and 45 SSRI-treated women were analysed by means of qPCR using custom-designed TaqMan low-density arrays (TLDAs) for 44 genes previously known to be involved in the pathophysiology of depression, and expressed in the placenta. Moreover, placental protein expression was determined by means of immunohistochemistry in 37 healthy controls, 13 women with untreated depression and 21 women on antidepressant treatment. Statistical comparisons between groups were performed by one-way ANOVA or the Kruskal–Wallis test. Results: Nominally significant findings were noted for HTR1A and NPY2R, where women with untreated depression displayed higher gene expression than healthy controls (p < 0.05), whereas women on antidepressant treatment had similar expression as healthy controls. The protein expression analyses revealed higher expression of HTR1A in placentas from women on antidepressant treatment, than in placentas from healthy controls (p < 0.05). Conclusion: The differentially expressed HTR1A, both at the gene and the protein level that was revealed in this study, suggests the involvement of HTR1A in the effect of antenatal depression on biological mechanisms in the placenta. More research is needed to elucidate the role of depression and antidepressant treatment on the placenta, and, further, the effect on the fetus.
- 1 August 2019
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 106, 1-8
Hypothalamic-pituitary-adrenal axis responsiveness, startle response, and sensorimotor gating in late pregnancy
- 1 August 2019
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 106, 1-8
Hypothalamic-pituitary-adrenal axis responsiveness, startle response, and sensorimotor gating in late pregnancy
- 1 May 2019
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 103, 296-305
Stress-related genetic polymorphisms in association with peripartum depression symptoms and stress hormones: A longitudinal population-based study
- 1 May 2019
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 103, 296-305
Stress-related genetic polymorphisms in association with peripartum depression symptoms and stress hormones: A longitudinal population-based study
- 20 November 2018
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 98 (4) , 470-478
Neuroticism is associated with higher antenatal care utilization in obstetric low‐risk women
Introduction Elevated neuroticism is associated with higher health care utilization in the general population. This study aimed to investigate the association between neuroticism and the use of publicly financed antenatal care in obstetric low‐risk women, also considering predisposing and need factors for health care utilization. Material and methods Participants comprised 1052 obstetric low‐risk women (no chronic diseases or adverse pregnancy conditions) included in several obstetrics/gynecology studies in Uppsala, Sweden. Neuroticism was self‐rated on the Swedish universities Scales of Personality. Medical records of their first subsequent pregnancy were scanned for antenatal care use. Associations between antenatal care use and neuroticism were analyzed with logistic regression (binary outcomes) or negative binomial regression (count outcomes) comparing the 75th vs 25th neuroticism percentiles. Depending on the Akaike information criterion the exposure was modeled as either linear or with restricted cubic splines. Analyses were adjusted for predisposing (sociodemographic and parity) and need factors (body mass index and psychiatric morbidity). Results After adjustment, women with higher neuroticism had more fetal ultrasounds (incidence rate ratio =1.09, 95% confidence interval (CI); 1.02 to 1.16), more emergency visits to an obstetrician/gynecologist (incidence rate ratio=1.22, 95%CI; 1.03 to 1.45), and were more likely to visit a fear‐of‐childbirth clinic (odds ratio=2.71, 95%CI; 1.71 to 4.29). Moreover, they more often consulted midwives in specialized antenatal care facilities (significant J‐shaped association). Conclusions Neuroticism was associated with higher utilization of publicly financed antenatal care in obstetric low‐risk women, even after adjusting for predisposing and need factors. Future studies should address the benefits of interventions as a complement to routine antenatal care programs to reduce subclinical anxiety.
- 20 November 2018
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 98 (4) , 470-478
Neuroticism is associated with higher antenatal care utilization in obstetric low‐risk women
Introduction Elevated neuroticism is associated with higher health care utilization in the general population. This study aimed to investigate the association between neuroticism and the use of publicly financed antenatal care in obstetric low‐risk women, also considering predisposing and need factors for health care utilization. Material and methods Participants comprised 1052 obstetric low‐risk women (no chronic diseases or adverse pregnancy conditions) included in several obstetrics/gynecology studies in Uppsala, Sweden. Neuroticism was self‐rated on the Swedish universities Scales of Personality. Medical records of their first subsequent pregnancy were scanned for antenatal care use. Associations between antenatal care use and neuroticism were analyzed with logistic regression (binary outcomes) or negative binomial regression (count outcomes) comparing the 75th vs 25th neuroticism percentiles. Depending on the Akaike information criterion the exposure was modeled as either linear or with restricted cubic splines. Analyses were adjusted for predisposing (sociodemographic and parity) and need factors (body mass index and psychiatric morbidity). Results After adjustment, women with higher neuroticism had more fetal ultrasounds (incidence rate ratio =1.09, 95% confidence interval (CI); 1.02 to 1.16), more emergency visits to an obstetrician/gynecologist (incidence rate ratio=1.22, 95%CI; 1.03 to 1.45), and were more likely to visit a fear‐of‐childbirth clinic (odds ratio=2.71, 95%CI; 1.71 to 4.29). Moreover, they more often consulted midwives in specialized antenatal care facilities (significant J‐shaped association). Conclusions Neuroticism was associated with higher utilization of publicly financed antenatal care in obstetric low‐risk women, even after adjusting for predisposing and need factors. Future studies should address the benefits of interventions as a complement to routine antenatal care programs to reduce subclinical anxiety.
- Open Access
- 1 August 2017
- Published by Elsevier in Hormones and Behavior
- Vol. 94, 106-113
Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway
- 1 August 2017
- Published by Elsevier in Hormones and Behavior
- Vol. 94, 106-113
Open AccessAllopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway
- Open Access
- 1 July 2016
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 69, 142-149
Tandem mass spectrometry determined maternal cortisone to cortisol ratio and psychiatric morbidity during pregnancy−interaction with birth weight
- 1 July 2016
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 69, 142-149
Open AccessTandem mass spectrometry determined maternal cortisone to cortisol ratio and psychiatric morbidity during pregnancy−interaction with birth weight
- 1 November 2015
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 61, 61
Corticotropin-releasing hormone and postpartum depression: A longitudinal study
- 1 November 2015
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 61, 61
Corticotropin-releasing hormone and postpartum depression: A longitudinal study
- Open Access
- 26 April 2014
- Published by S. Karger AG in Neuropsychobiology
- Vol. 69 (3) , 147-153
Low Serum Allopregnanolone Is Associated with Symptoms of Depression in Late Pregnancy
Background: Allopregnanolone (3α-hydroxy-5α-pregnan-20-one) is a neurosteroid which has an inhibitory function through interaction with the GABAA receptor. This progesterone metabolite has strong sedative and anxiolytic properties, and low endogenous levels have been associated with depressed mood. This study aimed to investigate whether the very high serum allopregnanolone levels in late pregnancy covary with concurrent self-rated symptoms of depression and anxiety. Methods: Ninety-six women in pregnancy weeks 37-40 rated symptoms of depression and anxiety with the Montgomery-Åsberg Depression Rating Scale (MADRS-S) and Spielberger State-Trait Anxiety Inventory. Their serum allopregnanolone was analyzed by Celite chromatography and radioimmunoassay. Results: Ten women had elevated depression scores (MADRS-S ≥13), and this group had significantly lower allopregnanolone levels compared to women with MADRS-S scores in the normal range (39.0 ± 17.9 vs. 54.6 ± 18.7 nmol/l, p = 0.014). A significant negative correlation was found between self-rated depression scores and allopregnanolone concentrations (Pearson's correlation coefficient = -0.220, p = 0.031). The linear association between self-rated depression scores and allopregnanolone serum concentrations remained significant when adjusted for gestational length, progesterone levels, and parity. Self-rated anxiety, however, was not associated with allopregnanolone serum concentrations during pregnancy. Conclusion: High allopregnanolone serum concentrations may protect against depressed mood during pregnancy.
- 26 April 2014
- Published by S. Karger AG in Neuropsychobiology
- Vol. 69 (3) , 147-153
Open AccessLow Serum Allopregnanolone Is Associated with Symptoms of Depression in Late Pregnancy
Background: Allopregnanolone (3α-hydroxy-5α-pregnan-20-one) is a neurosteroid which has an inhibitory function through interaction with the GABAA receptor. This progesterone metabolite has strong sedative and anxiolytic properties, and low endogenous levels have been associated with depressed mood. This study aimed to investigate whether the very high serum allopregnanolone levels in late pregnancy covary with concurrent self-rated symptoms of depression and anxiety. Methods: Ninety-six women in pregnancy weeks 37-40 rated symptoms of depression and anxiety with the Montgomery-Åsberg Depression Rating Scale (MADRS-S) and Spielberger State-Trait Anxiety Inventory. Their serum allopregnanolone was analyzed by Celite chromatography and radioimmunoassay. Results: Ten women had elevated depression scores (MADRS-S ≥13), and this group had significantly lower allopregnanolone levels compared to women with MADRS-S scores in the normal range (39.0 ± 17.9 vs. 54.6 ± 18.7 nmol/l, p = 0.014). A significant negative correlation was found between self-rated depression scores and allopregnanolone concentrations (Pearson's correlation coefficient = -0.220, p = 0.031). The linear association between self-rated depression scores and allopregnanolone serum concentrations remained significant when adjusted for gestational length, progesterone levels, and parity. Self-rated anxiety, however, was not associated with allopregnanolone serum concentrations during pregnancy. Conclusion: High allopregnanolone serum concentrations may protect against depressed mood during pregnancy.
- Open Access
- 1 December 2013
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 38 (12) , 3150-3154
Cortisol awakening response in late pregnancy in women with previous or ongoing depression
- 1 December 2013
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 38 (12) , 3150-3154
Open AccessCortisol awakening response in late pregnancy in women with previous or ongoing depression
- Open Access
- 7 February 2012
- Published by Springer Nature in Archives of Women's Mental Health
- Vol. 15 (2) , 87-94
Decreased startle modulation during anticipation in the postpartum period in comparison to late pregnancy
Knowledge about healthy women’s psychophysiological adaptations during the large neuroendocrine changes of pregnancy and childbirth is essential in order to understand why these events have the potential to disrupt mental health in vulnerable individuals. This study aimed to compare startle response modulation, an objective psychophysiological measure demonstrated to be influenced by anxiety and depression, longitudinally across late pregnancy and the postpartum period. The acoustic startle response modulation was assessed during anticipation of affective images and during image viewing in 31 healthy women during gestational weeks 36–39 and again at 4 to 6 weeks postpartum. No startle modulation by affective images was observed at either time point. Significant modulation during anticipation stimuli was found at pregnancy assessment but was reduced in the postpartum period. The women rated the unpleasant images more negative and more arousing and the pleasant images more positive at the postpartum assessment. Self-reported anxiety and depressive symptoms did not change between assessments. The observed postpartum decrease in modulation of startle by anticipation suggests a relatively deactivated defense system in the postpartum period.
- 7 February 2012
- Published by Springer Nature in Archives of Women's Mental Health
- Vol. 15 (2) , 87-94
Open AccessDecreased startle modulation during anticipation in the postpartum period in comparison to late pregnancy
Knowledge about healthy women’s psychophysiological adaptations during the large neuroendocrine changes of pregnancy and childbirth is essential in order to understand why these events have the potential to disrupt mental health in vulnerable individuals. This study aimed to compare startle response modulation, an objective psychophysiological measure demonstrated to be influenced by anxiety and depression, longitudinally across late pregnancy and the postpartum period. The acoustic startle response modulation was assessed during anticipation of affective images and during image viewing in 31 healthy women during gestational weeks 36–39 and again at 4 to 6 weeks postpartum. No startle modulation by affective images was observed at either time point. Significant modulation during anticipation stimuli was found at pregnancy assessment but was reduced in the postpartum period. The women rated the unpleasant images more negative and more arousing and the pleasant images more positive at the postpartum assessment. Self-reported anxiety and depressive symptoms did not change between assessments. The observed postpartum decrease in modulation of startle by anticipation suggests a relatively deactivated defense system in the postpartum period.